medigraphic.com
SPANISH

Revista Médica del Instituto Mexicano del Seguro Social

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2018, Number 2

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2018; 56 (2)

Quality of life in persons with Human Immunodeficiency Virus infection in Mexico

Quintero-Quiñónez JF, Goodman-Meza D, Burgos-Regil JL, Muñoz-Carvajal FA, Zúñiga-de Nuncio ML, Ornelas-Aguirre JM
Full text How to cite this article

Language: Spanish
References: 24
Page: 126-131
PDF size: 447.64 Kb.


Key words:

Acquired Immunodeficiency Syndrome.

ABSTRACT

Background: The evaluation of quality of life related to health (HRQOL) has become an important prognostic indicator in HIV/AIDS. The aim of this study was to determine the impact of socio-demographic, clinical and psychological factors in HRQOL in a group of subjects with HIV/AIDS in northwestern Mexico and determine which variables best predict HRQOL.
Methods: In a cross-sectional study with a sample of 87% of patients receiving care at a clinic for HIV/AIDS in northwestern Mexico between November 2010 to June 2011, we measure the HRQOL using the Tool Medical Outcomes Study HIV Health Survey (MOS-HIV). A model of multiple linear regression was performed to identify variables that allow us to predict HRQOL in this population.
Results: In a sample of 54 subjects with HIV/AIDS. Patients had an average age of 43 ± 9 years, 83% were men with a mean time of 6.5 ± 4.5 years from diagnosis. HRQOL scores of physical and mental health of the participants were 57 ± 6 and 57 ± 13 respectively. In multivariate analysis, the variables that influenced the physical health punctuation were gender, marital status, sexual orientation, time since diagnosis and viral load (log).
Conclusions: Prospective studies are needed to better explain the influence of the factors that predict changes or trends in HRQOL in patients with HIV/AIDS.


REFERENCES

  1. Valencia CP, Canaval GE, Marin D, Portillo CJ. Quality of life in persons living with HIV-AIDS in three healthcare institutions of Cali, Colombia. Colomb Med. 2010;41:206- 14.

  2. World Health Organization. Division of Mental Health and Prevention of Substance Abuse. Measuring Quality of life. Geneva, Switzerland: WHOQOL; 1997.

  3. Yen CF, Tsai JJ, Lu PL, Chen YH, Chen TC, Chen PP. Quality of life and its correlates in HIV/AIDS male outpatients receiving highly active antirretroviral therapy in Taiwan. Psychiatry Clin Neurosci. 2004;58(5):501-6.

  4. Wu AW, Dave NB, Diener-West M, Sorensen S, Huang IC, Revicki DA. Measuring validity of self-reported symptoms among people with HIV. AIDS Care. 2004;16(7):876-81.

  5. Urzua MA. Health related quality of life: Conceptual elements. Rev Med Chil. 2010;138(3):358-65.

  6. Phaladze NA, Human S, Dlamini SB, Hulela EB, Hadebe IM, Sukati NA, et al. Quality of life and the concept of living well with HIV/AIDS in sub-Saharan Africa. J Nurs Scholarsh. 2005;37(2):120-6.

  7. Guyatt GH, Feeny DH, Patrick DL. Measuring Healthrelated quality of life. Ann Intern Med. 1993;118(8):622-9.

  8. Briongos-Figuero LS, Bachiller-Luque P, Palacios-Martin T, González-Sagrado M, Eiros-Bouza JM. Assessment of factors influencing health-related quality of life in HIVinfected patients. HIV Med. 2011;12(1):22-30.

  9. Cardona-Arias JA, Higuita-Gutiérrez LF. Impact of HIV/AIDS on quality of life: meta-analysis 2002-2012. Rev Esp Salud Publica. 2014;88(1):87-101.

  10. Centro Nacional para la Prevención y el Control del VIH y el SIDA. Panorama Epidemiológico del VIH/SIDA e ITS en México. México: CENSIDA; 2016.

  11. Consejo Nacional para la Prevención y el Control del SIDA. Informe Nacional sobre los Progresos Realizados en la Aplicación del UNGASS/SIDA. México: CONASIDA; 2012.

  12. del Castillo LS, Ruiz-Pérez I, de Labry-Lima AO, Soto- Blanco JM, Girela-López E, Castro-Recio JM, et al. Influence of antiretroviral treatment on quality of life in seropositive inmates. Int J STD AIDS. 2008;19(3):172-7.

  13. Carrieri P, Spire B, Duran S, Katlama C, Peyramond D, Franςois C, et al. Health-related quality of life after 1 year of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2003;32(1):38-47.

  14. Peña-de Leon E, Aguilar-Gaytán SS, Suárez-Mendoza AA, Reyes-Terán G. A validation of the MOS-HIV quality of life measure in HIV-infected patients in Mexico. Rev Panam Salud Pública. 2007;21(5):313-9. 2

  15. Herrera C, Campero L, Caballero M, Kendall T. Relationship between physicians and HIV patients: influence on adherence and quality of life. Rev Saude Publica. 2008;42(2):249-55.

  16. Revicki DA, Sorensen S, Wu AW. Reliability and Validity of Physical and Mental Health Summary Scores from the Medical Outcomes Study HIV Health Survey. Med Care. 1998;36(2):126-37.

  17. Wu AW, Hays RD, Kelly S, Malitz F, Bozzette SA. Applications of the medical outcomes study health-related quality of life measures in HIV/AIDS. Qual Life Res. 1997;6(6):531-54.

  18. Wu AW, Revicki DA, Jacobson D, Malitz FE. Evidence for reliability validity and usefulness of the medical outcomes study HIV health survey (MOS-HIV). Qual Life Res. 1997;6(6):481-93.

  19. Miners AH, Sabin CA, Mocroft A, Youle M, Fisher M, Johnson M. Health-related quality of life in individuals infected with HIV in the era of HAART. HIV Clin Trials. 2001;2(6):484-92.

  20. Ruiz-Pérez I, Rodríguez-Baño J, López-Ruz MA, del Arco-Jimenez A, Causse-Prados M, Pasquau-Liñao J, et al. Health-related quality of life of patients with HIV: impact of sociodemographic, clinical and psychosocial factors. Qual Life Res. 2005;14(5):1301-10.

  21. Park-Wyllie LY, Strike CS, Antoniou T, Bayoumi AM. Adverse quality of life consequences of antiretroviral medications. AIDS Care. 2007;19(2):252-7.

  22. Hays RD, Cunningham WE, Sherbourne CD, Wilson IB, Wu AW, Cleary PD, et al. Health-related quality of life in patients with human immunodeficiency virus infection in the United States: Results from the HIV Cost and Services Utilization Study. Am J Med. 2000;108(9):714-22.

  23. Kalichman SC, Simbayi LC, Cloete A, Mthembu PP, Mkhonta RN, Ginindza T. Measuring AIDS stigmas in people living with HIV/AIDS: the Internalized AIDS-Related Stigma Scale. AIDS Care. 2009;21(1):87-93.

  24. Egger M, Hirschel B, Francioli P, Sudre P, Wirz M, Flepp M, et al. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: Prospective multicentre study. Swiss HIV Cohort Study. BMJ. 1997;315(7117):1194-9.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Inst Mex Seguro Soc. 2018;56